Back

Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention

27 August 2023 (13:15 - 13:55)
Organised by: Logo
Congress Presentation Part of: Revascularisation options in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Diem Dinh

Monash University, Victoria (Australia)

7 More presentations in this session

Presentation thumbnail
Impact of revascularization on non-flow limiting lesions
Mr C. Boerhout (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Comparison among ultra-thin coronary stents: a network metanalysis
Doctor F. Bruno (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Drug coated balloons-based approach versus conventional percutaneous coronary intervention with drug eluting stents for left anterior descending revascularization
Doctor M. Gitto (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmia without acute coronary syndrome as an indication for invasive coronary angiography
Doctor S. Kriechbaum (Bad Nauheim, DE)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of patients with late presentation STEMI undergoing percutaneous coronary revascularization.
Doctor P. Neef (Clydebank, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Revascularisation options in coronary artery disease

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Acute coronary syndromes without the usual suspects: prevalence and clinical outcomes of patients without standard modifiable risk factors (SMuRF-less)
thumbnail
Congress Presentation
Clinical outcomes of patients undergoing percutaneous coronary intervention for coronary artery disease without standard modifiable cardiovascular risk factors according to clinical presentation
thumbnail
Congress Presentation
Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources